Medical cannabis in Europe Between opportunities, challenges, and pioneering work by Helvezia Pharma & Medical Care AG
Hemp, a plant with a millennia-old history in rope and oil production, is experiencing a remarkable renaissance – not as an intoxicant, but as a potential medicine. The focus of intensive research is on the active ingredients tetrahydrocannabinol (THC) and cannabidiol (CBD). This article examines the effectiveness of cannabis medicines, the regulatory aspects in Europe, […]
European Charter: Long-Term Care, Health and Well-Being
Regulations for nursing homes are designed to protect and empower. This is a sensitive industry that directly affects the health and well-being of vulnerable people, such as the elderly or those in need of care. Contribution to the discussion by Max Leber, Managing Director of PPE Germany GmbH from Berlin.